No Data
No Data
Emergent BioSolutions Starts Enrollment in Africa or CDC-led MPox Study
Express News | Emergent BioSolutions Inc - First Interim Analysis of Mosa Trial Expected by End of Q1 2025
Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
Express News | Enrollment Starts in Africa Cdc-Led Mpox Therapeutic Study (Mosa)
Emergent BioSolutions Outlines Growth at J.P. Morgan Conference
Government Contract Update: $17M Payment to EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
HUANG AI : thanks for sharing
magickbeans710 : Thanks man
103567231 : Bro. I saw your post, noticed those colorful ones, but they have already started to skyrocket. I dare not buy. How did you get this information? We are all too late to Buy. Thank you.
Jaguar8 OP 103567231 : Whoever is telling you to buy anyway? It’s your decision and it’s MY WATCHLIST.
Jaguar8 OP 103567231 : Unfollow me and make your own watchlist.
View more comments...